In vivo mapping of fractional plasma volume (FPV) and endothelial transfer coefficient (KPS) in solid tumors using a macromolecular contrast agent: Correlation with histology and ultrastructure

International Journal of Cancer

Volumn 104, Issue 4, 2003, Pages 462-468

  Marzola, Pasquina ^a   Farace, Paolo ^a   Calderan, Laura ^a   Crescimanno, Caterina ^a   Lunati, Ernesto ^a   Nicolato, Elena ^a   Benati, Donatella ^a   Degrassi, Anna ^b   Terron, Andrea ^b   Klapwijk, Jan ^b   Pesenti, Enrico ^b   Sbarbati, Andrea ^a   Osculati, Francesco ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Pharmacia   (Italy)

Author keywords

CD3I; Magnetic resonance, imaging; Microvasculature; Mouse; Neoplasia; Ultrastructure

Indexed keywords

CONTRAST MEDIUM;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENDOTHELIUM LESION; HISTOLOGY; HUMAN; HUMAN CELL; HYDROSTATIC PRESSURE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MACROMOLECULE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PLASMA VOLUME; PRIORITY JOURNAL; SOLID TUMOR; TUMOR NECROSIS; TUMOR VASCULARIZATION; ULTRASTRUCTURE;

ANIMALS; CONTRAST MEDIA; ENDOTHELIUM, VASCULAR; HUMANS; IMAGE ENHANCEMENT; MACROMOLECULAR SUBSTANCES; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PERMEABILITY; PLASMA VOLUME;

EID: 0037457488     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10953     Document Type: Article

References (31)

1. Li WW. Tumor angiogenesis: molecular pathology, therapeutic targeting and imaging. Acad Radiol 2000;7:800-811
2. Folkman J, Becker K. Angiogenesis imaging. Acad Radiol 2000;7:783-785.
3. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladstone SR, Friedman M, Sellke FW, Simons M. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995;1:1085-9.
4. Saeed M, Wendland MF, Higgins CB. The developing role of magnetic resonance contrast media in the detection of ischemic heart disease. Proc Soc Exp Biol Med 1995;208:238-54.
5. Brasch RC, Li KC, Husband JE, Keogan MT, Neeman M, Padhani AR, Shames D, Turetschek T. In vivo monitoring of tumor angiogenesis with MR imaging. Acad Radiol 2000;7:812-23.
6. Demsar F, Roberts TP, Schwickert HC, Shames DM, van Dijke CF, Mann JS, Saeed M, Brasch RC. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997;37:236-42.
7. Ogan M, Schmiedl U, Moseley M, Grodd W, Paajenen H, Brasch R. Albumin labeled with Gd-DTPA: an intravascular contrast enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987;22:665-671.
8. Stanisz GJ, Henkelman RM. Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med 2000;44:665-667.
9. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histological tumor grade: comparison of macromolecular and small-molecular contrast media. Pediatr Radiol 1998;28:67-78.
10. Haase A, Matthaei D, Bartkowski R, Duhmke E, Leibfritz D. Inversion recovery snapshot FLASH MR imaging. J Comput Assist Tomogr 1989;13:1036-40.9.
11. Bhujwalla ZM, Artemov D, Glockner J. Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging. Topics Magn Resonance Imaging 1999;10:92-103.
12. Patlak C, Blasberg R, Fenstermacher J. Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
13. Beauregard DA, Hill SA, Chaplin DJ, Brindle KM. The susceptibility of tumors to the antivascular drug combrestatin A4 phosphate correlates with vascular permeability. Cancer Research 2001;61:6811-5.
14. Brasch R, Pham C, Shames D, Roberts T, van Dijke K, van Bruggen N, Mann J, Ostrowitzki S, Melnyk O. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
15. Beckstead JH. A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. J Histochem Cytochem 1994;42:1127-34.
16. Kubitza M, Hickey L, Roberts WG. Influence of host microvascular environment on tumour vascular endothelium. Int J Exp Pathol 1999;80:1-10.
17. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998;95:4607-12.
18. Krol A, Maresca J, Dewhirst MW, Yuan F. Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery. Cancer Res 1999;15;59:4136-41.
19. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Microcirculation 1997;4:1-23.
20. Monsky WL, Fukumura D, Gohongi T, Ancukiewcz M, Weich HA, Torchilin VP, Yuan F, Jain RK. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res 1999;59:4129-35.
21. Hashizume H, Baluk P, Morikawa S, McLean JW, Thrston G, Roberge S, Jain RK, McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80.
22. Schlingemann RO, Rietveld FJ, Kwaspen F, van de Kerkhof PC, de Waal RM, Ruiter DJ. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol 1991;138:1335-47.
23. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endhotelial grow factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995;146:5.
24. Paku S, Paweletz N. First steps of tumor-related angiogenesis. Lab Invest 1991;65:334-46.
25. Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 996;59:100-15.
26. Kohn S, Nagy JA, Dvorak HF, Dvorak AM. Pathways of macromolecular tracer transport across venules and small veins: structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 1992;67:596-607.
27. Qu-Hong, Nagy JA, Senger DR, Dvorak HF, Dvorak AM. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem 1995;43:381-9.
28. Dvorak AM, Feng D. The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem 2001;49:419-32.
29. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995:108:2369-79.
30. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 1997;15;57:765-72.
31. Roberts WG, Delaat J, Nagane M, Huang S, Cavenes WK, Palade GE. Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol 1998;153:1239.